Advise the patient to read the FDA-approved patient labeling (Patient Information).
Diarrhea
Hepatotoxicity
Embryo-Fetal Toxicity
Lactation
Infertility
Manufactured for:
Seagen Inc.
Bothell, WA 98021
1-855-4SEAGEN
TUKYSA, Seagen, and are US registered trademarks of Seagen Inc.
© 2023 Seagen Inc., Bothell, WA 98021. All rights reserved.
USPI-213411-v04
This Patient information has been approved by the U.S. Food and Drug Administration Revised: 01/2023 | |||
PATIENT INFORMATION TUKYSA (too-KYE-sah) (tucatinib) tablets | |||
Important information: If your healthcare provider prescribes TUKYSA in combination with capecitabine for your breast cancer, also read the Patient Information that comes with capecitabine. | |||
What is TUKYSA? TUKYSA is a prescription medicine used to treat adults with:
| |||
Before taking TUKYSA, tell your healthcare provider about all of your medical conditions, including if you: | |||
| |||
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TUKYSA may affect the way your other medicines work, and other medicines may affect the way TUKYSA works. Know the medicines you take. Keep a list of all the medicines you take and show it to your healthcare provider and pharmacist every time you get a new medicine.. | |||
How should I take TUKYSA? | |||
| |||
What are the possible side effects of TUKYSA? TUKYSA may cause serious side effects, including: | |||
| |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab and capecitabine in adults with HER2-positive breast cancer include: | |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab in adults with RAS wild-type HER2-positive colorectal cancer include: | |||
|
| ||
Your healthcare provider may change your dose of TUKYSA, temporarily stop, or permanently stop treatment with TUKYSA if you have certain side effects. TUKYSA may cause fertility problems in males and females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility. These are not all of the possible side effects of TUKYSA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How should I store TUKYSA? | |||
| |||
Keep TUKYSA and all medicines out of reach of children. | |||
General information about the safe and effective use of TUKYSA. Medicines are sometimes prescribed for conditions not listed in the Patient Information. Do not use TUKYSA for a condition for which it was not prescribed. Do not give TUKYSA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about TUKYSA that is written for healthcare professionals. | |||
What are the ingredients in TUKYSA? Active ingredient: tucatinib Inactive ingredients: Tablet core: copovidone, crospovidone, sodium chloride, potassium chloride, sodium bicarbonate, colloidal silicon Tablet coating: yellow film coat: polyvinyl alcohol, titanium dioxide, macrogol/polyethylene glycol, talc, and yellow iron oxide non-irradiated. Manufactured for Seagen Inc., Bothell, WA 98021 TUKYSA is a registered trademark owned by Seagen Inc. ©2023 Seagen Inc. PPI-213411-v04 For more information, call 1-855-473-2436 (1-855-4SEAGEN) or go to www.TUKYSA.com.. |
Advise the patient to read the FDA-approved patient labeling (Patient Information).
Diarrhea
Hepatotoxicity
Embryo-Fetal Toxicity
Lactation
Infertility
Manufactured for:
Seagen Inc.
Bothell, WA 98021
1-855-4SEAGEN
TUKYSA, Seagen, and are US registered trademarks of Seagen Inc.
© 2023 Seagen Inc., Bothell, WA 98021. All rights reserved.
USPI-213411-v04
This Patient information has been approved by the U.S. Food and Drug Administration Revised: 01/2023 | |||
PATIENT INFORMATION TUKYSA (too-KYE-sah) (tucatinib) tablets | |||
Important information: If your healthcare provider prescribes TUKYSA in combination with capecitabine for your breast cancer, also read the Patient Information that comes with capecitabine. | |||
What is TUKYSA? TUKYSA is a prescription medicine used to treat adults with:
| |||
Before taking TUKYSA, tell your healthcare provider about all of your medical conditions, including if you: | |||
| |||
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TUKYSA may affect the way your other medicines work, and other medicines may affect the way TUKYSA works. Know the medicines you take. Keep a list of all the medicines you take and show it to your healthcare provider and pharmacist every time you get a new medicine.. | |||
How should I take TUKYSA? | |||
| |||
What are the possible side effects of TUKYSA? TUKYSA may cause serious side effects, including: | |||
| |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab and capecitabine in adults with HER2-positive breast cancer include: | |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab in adults with RAS wild-type HER2-positive colorectal cancer include: | |||
|
| ||
Your healthcare provider may change your dose of TUKYSA, temporarily stop, or permanently stop treatment with TUKYSA if you have certain side effects. TUKYSA may cause fertility problems in males and females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility. These are not all of the possible side effects of TUKYSA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How should I store TUKYSA? | |||
| |||
Keep TUKYSA and all medicines out of reach of children. | |||
General information about the safe and effective use of TUKYSA. Medicines are sometimes prescribed for conditions not listed in the Patient Information. Do not use TUKYSA for a condition for which it was not prescribed. Do not give TUKYSA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about TUKYSA that is written for healthcare professionals. | |||
What are the ingredients in TUKYSA? Active ingredient: tucatinib Inactive ingredients: Tablet core: copovidone, crospovidone, sodium chloride, potassium chloride, sodium bicarbonate, colloidal silicon Tablet coating: yellow film coat: polyvinyl alcohol, titanium dioxide, macrogol/polyethylene glycol, talc, and yellow iron oxide non-irradiated. Manufactured for Seagen Inc., Bothell, WA 98021 TUKYSA is a registered trademark owned by Seagen Inc. ©2023 Seagen Inc. PPI-213411-v04 For more information, call 1-855-473-2436 (1-855-4SEAGEN) or go to www.TUKYSA.com.. |
Advise the patient to read the FDA-approved patient labeling (Patient Information).
Diarrhea
Hepatotoxicity
Embryo-Fetal Toxicity
Lactation
Infertility
Manufactured for:
Seagen Inc.
Bothell, WA 98021
1-855-4SEAGEN
TUKYSA, Seagen, and are US registered trademarks of Seagen Inc.
© 2023 Seagen Inc., Bothell, WA 98021. All rights reserved.
USPI-213411-v04
This Patient information has been approved by the U.S. Food and Drug Administration Revised: 01/2023 | |||
PATIENT INFORMATION TUKYSA (too-KYE-sah) (tucatinib) tablets | |||
Important information: If your healthcare provider prescribes TUKYSA in combination with capecitabine for your breast cancer, also read the Patient Information that comes with capecitabine. | |||
What is TUKYSA? TUKYSA is a prescription medicine used to treat adults with:
| |||
Before taking TUKYSA, tell your healthcare provider about all of your medical conditions, including if you: | |||
| |||
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TUKYSA may affect the way your other medicines work, and other medicines may affect the way TUKYSA works. Know the medicines you take. Keep a list of all the medicines you take and show it to your healthcare provider and pharmacist every time you get a new medicine.. | |||
How should I take TUKYSA? | |||
| |||
What are the possible side effects of TUKYSA? TUKYSA may cause serious side effects, including: | |||
| |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab and capecitabine in adults with HER2-positive breast cancer include: | |||
|
| ||
The most common side effects of TUKYSA in combination with trastuzumab in adults with RAS wild-type HER2-positive colorectal cancer include: | |||
|
| ||
Your healthcare provider may change your dose of TUKYSA, temporarily stop, or permanently stop treatment with TUKYSA if you have certain side effects. TUKYSA may cause fertility problems in males and females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility. These are not all of the possible side effects of TUKYSA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How should I store TUKYSA? | |||
| |||
Keep TUKYSA and all medicines out of reach of children. | |||
General information about the safe and effective use of TUKYSA. Medicines are sometimes prescribed for conditions not listed in the Patient Information. Do not use TUKYSA for a condition for which it was not prescribed. Do not give TUKYSA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about TUKYSA that is written for healthcare professionals. | |||
What are the ingredients in TUKYSA? Active ingredient: tucatinib Inactive ingredients: Tablet core: copovidone, crospovidone, sodium chloride, potassium chloride, sodium bicarbonate, colloidal silicon Tablet coating: yellow film coat: polyvinyl alcohol, titanium dioxide, macrogol/polyethylene glycol, talc, and yellow iron oxide non-irradiated. Manufactured for Seagen Inc., Bothell, WA 98021 TUKYSA is a registered trademark owned by Seagen Inc. ©2023 Seagen Inc. PPI-213411-v04 For more information, call 1-855-473-2436 (1-855-4SEAGEN) or go to www.TUKYSA.com.. |
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.